Blog

Walmart (NYSE: WMT) was struggling to keep pace with Amazon (NASDAQ: AMZN) when Doug McMillon became the retail giant's CEO in 2014. Its superstores were becoming showrooms for Amazon's online

E-commerce has grown dramatically in recent years, but the vast majority of retail sales still take place the old-fashioned way, in stores. In this Fool Live clip, recorded on June 15, Millionacres

Cutting-edge pharma Legend Biotech (NASDAQ: LEGN) burst onto the scene at the 2017 American Society of Clinical Oncology (ASCO) meeting with fantastic early clinical trial results for its multiple

Many people overestimate what Social Security benefits can do for them in their later years. If you're one of them, you could find yourself with a financial shortfall in retirement. 

It's best to

If you have $5,000 available to invest in stocks, there are some great options out there for you. The three stocks I have listed below are underrated investments and are trading at low earnings

Johnson & Johnson (NYSE: JNJ) hasn't become the major player in the COVID-19 vaccine market that many expected it to be, in large part because of manufacturing issues at a contractor's facility

The ongoing COVID-19 pandemic has devastated countless businesses alongside its obvious human cost. But there are those companies that have benefited because their products were in high demand

Buying shares of top tech stocks Facebook, Apple, Amazon, Netflix, and Alphabet (Google) -- otherwise known as FAANG -- would have earned great returns in the past. But now, with their valuations

When you need money in a pinch, there's always the option to go to a bank or lending institution and ask for a loan. But why have to beg for a loan when you have money sitting in your very own

Many investors are aware of the reasons to invest in Johnson & Johnson (NYSE: JNJ). It is big, diversified, and sports one of the healthier dividend yields in the Dow Jones Industrial Average (DJIND

According to the IRS, the average tax refund this year has been $2,775, just 0.3% higher than last year's total of $2,767. While many people may use that money to pay down bills or end up spending

A good way to maximize your odds of success when investing in the cannabis industry is by buying shares of low-cost producers. Profitability is hard to come by in the sector, especially in the

Biogen's (NASDAQ: BIIB) stock roared on June 7 after the unexpected approval of its Alzheimer's disease drug, Aduhelm. Now, the entire biopharma industry is alight with criticism of the U.S. Food

Onion Global (NYSE: OG) has been one of the worst tech IPOs of 2021. The Chinese e-commerce company went public at $7.25 per share in early May, closed at $7 on the first day, and is now only worth

AstraZeneca (NASDAQ: AZN) has hit quite a few speed bumps in commercializing its COVID-19 vaccine. The latest problem for the company is that a top European official is warning to avoid

Sundial Growers (NASDAQ: SNDL) has been a perplexing stock to watch this year. It doesn't have a pending U.S. acquisition in place like Canopy Growth does with Acreage Holdings, and it hasn't closed

Despite operating in the same business, Cinemark's (NYSE: CNK) stock has not gained nearly as much attention as AMC Entertainment Holdings (NYSE: AMC). Over the last month, AMC stock experienced an

Fulgent Genetics (NASDAQ: FLGT) is arguably the cheapest coronavirus stock on the market -- if not the cheapest biotech of any type out here, with a price-to-earnings (P/E) valuation of just 6.6.

For nearly six months, retail investors have ruled the roost on Wall Street. Even though retail investors have been putting their money to work in the market for over 100 years, they've never had

Biogen (NASDAQ: BIIB) received fantastic news in early June with the U.S. Food and Drug Administration (FDA) approved Aduhelm in treating Alzheimer's disease. However, the drugmaker has reported

Many financial experts recommend waiting until the age of 70 to claim Social Security, and with good reason. Delaying increases your monthly income and gives you a good chance to earn the maximum

Back on May 26, when the company announced its first-quarter earnings, NVIDIA (NASDAQ: NVDA) also detailed plans to initiate a 4-for-1 split on July 19. The stock has since climbed more than 21% in

Holding a stock for 10 years may sound crazy to some, but your job as an investor is exponentially easier if you can commit to holding this long. Consider that you can pick a great stock and have a

Imagine having a product that generated sales of $919 million last year. Now picture having to stop deliveries of that product not just in one market but across the entire world. That's the

This year was shaping up to be a miserable one for Clover Health (NASDAQ: CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's